Cargando…

Down-regulation of kallikrein-related peptidase 5 (KLK5) expression in breast cancer patients: a biomarker for the differential diagnosis of breast lesions

BACKGROUND: Kallikrein-related peptidase 5 (KLK5) is a secreted trypsin-like protease of the KLK family, encoded by the KLK5 gene. KLK5 has been found to cleave various extracellular matrix components, as well as to activate several other KLK proteases, triggering the stimulation of tissue microenvi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Avgeris, Margaritis, Papachristopoulou, Georgia, Polychronis, Athanasios, Scorilas, Andreas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer 2011
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3167201/ https://www.ncbi.nlm.nih.gov/pubmed/21906360 http://dx.doi.org/10.1186/1559-0275-8-5

Ejemplares similares

Molecular cloning of novel transcripts of human kallikrein-related peptidases 5, 6, 7, 8 and 9 (KLK5 – KLK9), using Next-generation sequencing
por: Adamopoulos, Panagiotis G., et al.
Publicado: (2017)

Emerging clinical importance of the cancer biomarkers kallikrein-related peptidases (KLK) in female and male reproductive organ malignancies
por: Schmitt, Manfred, et al.
Publicado: (2013)

Kallikrein-Related Peptidase 12 (KLK12) in Breast Cancer as a Favorable Prognostic Marker
por: Sato, Ai, et al.
Publicado: (2023)

Human kallikrein gene 5 (KLK5) expression is an indicator of poor prognosis in ovarian cancer
por: Kim, H, et al.
Publicado: (2001)

The androgen-regulated gene human kallikrein 15 (KLK15) is an independent and favourable prognostic marker for breast cancer
por: Yousef, G M, et al.
Publicado: (2002)

Prognostic value of kallikrein-related peptidase 12 (KLK12) mRNA expression in triple-negative breast cancer patients
por: Gong, Weiwei, et al.
Publicado: (2020)

Human kallikrein gene 13 (KLK13) expression by quantitative RT–PCR: an independent indicator of favourable prognosis in breast cancer
por: Chang, A, et al.
Publicado: (2002)

Kallikrein-related peptidase-4 (KLK4): role in enamel formation and revelations from ablated mice
por: Bartlett, John D., et al.
Publicado: (2014)

Mass spectrometry-based determination of Kallikrein-related peptidase 7 (KLK7) cleavage preferences and subsite dependency
por: Silva, Lakmali Munasinghage, et al.
Publicado: (2017)

Prospective quantitative gene expression analysis of kallikrein-related peptidase KLK10 as a diagnostic biomarker for childhood acute lymphoblastic leukemia
por: Ahmad, Shwan Majid, et al.
Publicado: (2022)

Kallikrein-related peptidase 5 induces miRNA-mediated anti-oncogenic pathways in breast cancer
por: Sidiropoulos, Konstantinos G., et al.
Publicado: (2014)

The KLK5 protease suppresses breast cancer by repressing the mevalonate pathway
por: Pampalakis, Georgios, et al.
Publicado: (2013)

Kallikrein family proteases KLK6 and KLK7 are potential early detection and diagnostic biomarkers for serous and papillary serous ovarian cancer subtypes
por: Tamir, Ayala, et al.
Publicado: (2014)

The use of kallikrein-related peptidases as adjuvant prognostic markers in colorectal cancer
por: Talieri, M, et al.
Publicado: (2009)

Prognostic value of kallikrein-related peptidase 7 (KLK7) mRNA expression in advanced high-grade serous ovarian cancer
por: Gong, Weiwei, et al.
Publicado: (2020)

Expression of human Kallikrein 14 (KLK14) in breast cancer is associated with higher tumour grades and positive nodal status
por: Fritzsche, F, et al.
Publicado: (2006)

Development of Chemical Tools to Monitor Human Kallikrein 13 (KLK13) Activity
por: Gruba, Natalia, et al.
Publicado: (2019)

Characterization of kallikrein-related peptidase 4 (KLK4) mRNA expression in tumor tissue of advanced high-grade serous ovarian cancer patients
por: Gong, Weiwei, et al.
Publicado: (2019)

Loss of GAS5 tumour suppressor lncRNA: an independent molecular cancer biomarker for short-term relapse and progression in bladder cancer patients
por: Avgeris, Margaritis, et al.
Publicado: (2018)

Kallikrein-Related Peptidase 6 (KLK6) as a Contributor toward an Aggressive Cancer Cell Phenotype: A Potential Role in Colon Cancer Peritoneal Metastasis
por: Bouzid, Hayet, et al.
Publicado: (2022)

Metastasis of ovarian cancer is mediated by kallikrein related peptidases
por: Dong, Ying, et al.
Publicado: (2013)

Identification of a STAT5 Target Gene, Dpf3, Provides Novel Insights in Chronic Lymphocytic Leukemia
por: Theodorou, Marina, et al.
Publicado: (2013)

Genetically-modified stem cells in treatment of human diseases: Tissue kallikrein (KLK1)-based targeted therapy (Review)
por: Devetzi, Marina, et al.
Publicado: (2018)

A Pair of Prognostic Biomarkers in Triple-Negative Breast Cancer: KLK10 and KLK11 mRNA Expression
por: Liu, Yueyang, et al.
Publicado: (2022)

Evolution of the Plasma and Tissue Kallikreins, and Their Alternative Splicing Isoforms
por: Koumandou, Vassiliki Lila, et al.
Publicado: (2013)

tRNA-Derived Fragments (tRFs) in Bladder Cancer: Increased 5′-tRF-LysCTT Results in Disease Early Progression and Patients’ Poor Treatment Outcome
por: Papadimitriou, Maria-Alexandra, et al.
Publicado: (2020)

Biochemical pathways mediated by KLK6 protease in breast cancer
por: Pampalakis, Georgios, et al.
Publicado: (2019)

KLK5 Inactivation Reverses Cutaneous Hallmarks of Netherton Syndrome
por: Furio, Laetitia, et al.
Publicado: (2015)

Natural and synthetic inhibitors of kallikrein-related peptidases (KLKs)
por: Goettig, Peter, et al.
Publicado: (2010)

Involvement of Kallikrein-Related Peptidases in Normal and Pathologic Processes
por: Stefanini, Ana Carolina B., et al.
Publicado: (2015)

Involvement of Kallikrein-Related Peptidases in Nervous System Disorders
por: Mella, Cinthia, et al.
Publicado: (2020)

KLK5 and KLK7 Ablation Fully Rescues Lethality of Netherton Syndrome-Like Phenotype
por: Kasparek, Petr, et al.
Publicado: (2017)

Overexpression of the GR Riborepressor LncRNA GAS5 Results in Poor Treatment Response and Early Relapse in Childhood B-ALL
por: Xagorari, Marieta, et al.
Publicado: (2021)

Expression of kallikrein-related peptidase 7 is decreased in prostate cancer
por: Zhang, Chong-Yu, et al.
Publicado: (2015)

Biomarker implication of kallikrein-related peptidases as prognostic tissue substrates of poor survival in colorectal cancer
por: Peng, Qiliang, et al.
Publicado: (2020)

Could Kallikrein-Related Serine Peptidase 3 Be an Early Biomarker of Environmental Exposure in Young Women?
por: Raimondo, Salvatore, et al.
Publicado: (2021)

Kallikrein-related peptidases 4, 5, 6 and 7 regulate tumour-associated factors in serous ovarian cancer
por: Wang, Ping, et al.
Publicado: (2018)

AB73. Effect of human tissue kallikrein 1(hKLK1) on penile erectile function in the aged rat
por: Liu, Ji-Hong
Publicado: (2014)

Identification of MFGE8 and KLK5/7 as mediators of breast tumorigenesis and resistance to COX-2 inhibition
por: Tian, Jun, et al.
Publicado: (2021)

Expression and function of the Kallikrein-related peptidase 6 in the human melanoma microenvironment
por: Krenzer, Stefanie, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_fef15m4a30mlft62ctj5embn5s